Acadian Asset Management

Acadian Asset Management’s Dianthus Therapeutics DNTH Stock Holding History

Acadian Asset Management’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,012	Closed	-$120K	–	1779
2024 Q1	$120K	Sell	4,012 -13,876	-78%	-$302K	﹤0.01%	1259
2023 Q4	$184K	Sell	17,888 -4,411	-20%	-$48.7K	﹤0.01%	1248
2023 Q3	$303K	Sell	22,299 -6,307	-22%	-$79.5K	﹤0.01%	1115
2023 Q2	$346K	Sell	28,606 -9,782	-25%	-$111K	﹤0.01%	1144
2023 Q1	$486K	Buy	38,388 +30,838	+408%	+$341K	﹤0.01%	1057
2022 Q4	$46K	Buy	7,550 +1,610	+27%	+$28.5K	﹤0.01%	1585
2022 Q3	$132K	Buy	5,940 +1,319	+29%	+$36.1K	﹤0.01%	1295
2022 Q2	$89K	Buy	4,621 +3,416	+283%	+$84.4K	﹤0.01%	1382
2022 Q1	$55K	Buy	1,205 +790	+190%	+$43.2K	﹤0.01%	1454
2021 Q4	$29K	Buy	+415	New	+$41.7K	﹤0.01%	1564

Other funds holding DNTH

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return